Pharma Journalist -

Bayer announced the acquisition of German biotech start-up Targenomix. The spin-off of the Max Planck Institute for Molecular Plant Physiology (MPI MPP) uses novel systems biology and…
Read More...

Pfizer Inc. and BioNTech SE announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY Original/Omicron BA.4/BA.5 5/5 µg) has been recommended for…
Read More...

Sobi announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret (anakinra) for the treatment of coronavirus disease 2019…
Read More...

After the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn Beta, the vaccine was approved by the European…
Read More...

Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. announced a brand new partnership focused on developing and sharing best practices in innovative manufacturing, product…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) in combination with platinum-based…
Read More...

NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, announced the closing of a £16 million Series A financing, led by Omega Funds and joined…
Read More...

Royalty Pharma plc and Arrowhead announced that Royalty Pharma has acquired a royalty interest in Amgen’s olpasiran from Arrowhead Pharmaceuticals for $250 million in cash upfront plus…
Read More...

A wholly-owned subsidiary of Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. announced the signing of a licensing agreement for commercialization of…
Read More...

ProPhase Labs, Inc. announced that its wholly owned subsidiary, ProPhase BioPharma, Inc. (“PBIO”), and Dana-Farber Cancer Institute have entered into a two-year collaborative agreement…
Read More...